Authors: BORBA EF BONFA E VINAGRE CG MESQUITA CH MARANHAO RC

Citation: Ef. Borba et al., IMPAIRED METABOLISM OF ARTIFICIAL CHYLOMICRONS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 282-282

Authors: BORBA EF BONFA E

Citation: Ef. Borba et E. Bonfa, DYSLIPOPROTEINEMIAS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - INFLUENCE OF DISEASE, ACTIVITY, AND ANTICARDIOLIPIN ANTIBODIES, Lupus, 6(6), 1997, pp. 533-539

Authors: BORBA EF BONFA E COSSERMILLI W

Citation: Ef. Borba et al., LIPOPROTEIN(A) AND OTHER RISK-FACTORS FOR THROMBOSIS IN RHEUMATOID-ARTHRITIS - REPLY, Journal of rheumatology, 23(1), 1996, pp. 195-196

Authors: BORBA EF COSSERMELLI W BONFA E

Citation: Ef. Borba et al., LIPID PROFILE IN SLE - INFLUENCE OF DISEASE, ACTIVITY, DRUGS AND ANTICARDIOLIPIN ANTIBODIES, Arthritis and rheumatism, 38(9), 1995, pp. 121-121

Authors: BORBA EF SANTOS RD BONFA E VINAGRE CG PILEGGI FJC COSSERMELLI W MARANHAO RC

Citation: Ef. Borba et al., LIPOPROTEIN(A) LEVELS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of rheumatology, 21(2), 1994, pp. 220-223

Authors: BORBA EF PEREIRA RMR VELLOSO EDRP PEREIRA IA GONCALVES CR YOSHINARI NH

Citation: Ef. Borba et al., NEUTROPENIA ASSOCIATED WITH MYELOFIBROSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Acta haematologica, 89(2), 1993, pp. 82-85